SCHEMBL20655261

SCHEMBL20655261

N#Cc1cc(C#N)cc(-c2ccc3c4ccccc4n(-c4ccc(-c5cc(-c6ccccc6)nc(-c6ccccc6)n5)cc4-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.37
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
ALDH1A1 P00352 5/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 2/20 0.37
LMNA P02545 4/20 0.36
KDM4E B2RXH2 2/20 0.36
GLA P06280 1/20 0.36
ALDH1A3 P47895 1/20 0.36
CYP1A2 P05177 5/20 0.35
CYP3A4 P08684 4/20 0.35
CLK4 Q9HAZ1 3/20 0.35
CYP2D6 P10635 3/20 0.35
TSHR P16473 3/20 0.35
CYP2C19 P33261 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP2C9 P11712 1/20 0.35
NTSR1 P30989 1/20 0.34
MAOA P21397 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20655605 1.00 ABCG2 (0.37) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655014 0.98 MEN1 (0.38) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655410 0.98 MEN1 (0.38) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655192 0.97 ALDH1A3 (0.36) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655608 0.97 KMT2A (0.39) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655259 0.97 KMT2A (0.39) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655160 0.96 ABCG2 (0.37) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655619 0.95 ALDH1A3 (0.42) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655411 0.95 KMT2A (0.39) ABCG2MEN1KMT2AALDH1A1MAPT
SCHEMBL20655012 0.95 KMT2A (0.39) ABCG2MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11005048-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-05-11 US disclosed
EP-3530659-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-08-28 EP disclosed
EP-3431473-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-01-23 EP disclosed
US-20190019960-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190019960-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OR51E2, ORC3 ABCG2 1151/4885MEN1 2977/4885KMT2A 4524/4885
US-11005048-B2 Organic molecules, in particular for use in optoelectronic devices OR10J3, OR51E2, ORC3 ABCG2 1151/4885MEN1 2977/4885KMT2A 4524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.